-
Mashup Score: 2CCTG HN13 study awarded funding in the Spring 2023 CIHR competition | Canadian Cancer Trials Group - 6 day(s) ago
CCTG HN13 clinical trial has successfully been awarded $1,602,675 in the Spring 2023 CIHR funding competition to investigate improving head and neck tumour and symptom control in patients who are unable to tolerate curative radiotherapy.
Source: www.ctg.queensu.caCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis - PubMed - 1 month(s) ago
Acute exposure to ionizing radiation can cause lethal damage to the gastrointestinal (GI) tract, a condition called the GI syndrome. Whether the target cells affected by radiation to cause the GI syndrome are derived from the epithelium or endothelium and whether the target cells die by apoptosis or …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Oncologists2Tweet-
Back in 2010, we reported in @ScienceMagazine that p53 acts in GI epithelial cells to protect the intestine from radiation injury, but the mechanism was unclear. https://t.co/KCTO4Mj71H 2/4
-
-
Mashup Score: 1Paid Summer Internship for Childhood Cancer Survivors - POGO - 2 month(s) ago
The First Avenue & EMBLEM Internship Program is open to young adults who have survived childhood cancer and are looking to experience one-on-one mentorship from leaders who care and support their development.
Source: www.pogo.caCategories: General Medicine News, Hem/OncsTweet-
RT @DrDHodgson: Paid Summer Internship for Childhood Cancer Survivors - POGO https://t.co/VeJcJorNlD
-
-
Mashup Score: 30Postdoctoral Fellow in Cancer Epigenomics - 3 month(s) ago
Post a job in 3min, or find thousands of job offers like this one at jobRxiv!
Source: jobrxiv.orgCategories: General Medicine News, Hem/OncsTweet-
RT @MatLupien: My lab is looking to recruit a postdoc. Full details available at https://t.co/RFXE6XgKie
-
-
Mashup Score: 4Dr. David Malkin Named 2024 AACR Fellow - 4 month(s) ago
MBP scientist Dr. David Malkin has been elected to the Fellows of the American Association for Cancer Research (AACR) Academy. The AACR Academy honours distinguished scientists like Dr. Malkin who have made major contributions to cancer research. Dr. Malkin is joining a select group of Canadians who have been named to the AACR Academy. Dr. Malkin has been recognized by the AACR for his…
Source: medbio.utoronto.caCategories: General Medicine News, Hem/OncsTweet-
RT @MBPatUofT: Dr. David Malkin Named 2024 AACR Fellow https://t.co/7GOobPqtvX #Cancer #CancerResearch #MedicalBiophysics #UofT https://t…
-
-
Mashup Score: 4Dr. David Malkin Named 2024 AACR Fellow - 4 month(s) ago
MBP scientist Dr. David Malkin has been elected to the Fellows of the American Association for Cancer Research (AACR) Academy. The AACR Academy honours distinguished scientists like Dr. Malkin who have made major contributions to cancer research. Dr. Malkin is joining a select group of Canadians who have been named to the AACR Academy. Dr. Malkin has been recognized by the AACR for his…
Source: medbio.utoronto.caCategories: General Medicine News, Hem/OncsTweet-
RT @MBPatUofT: Dr. David Malkin Named 2024 AACR Fellow https://t.co/7GOobPqtvX #Cancer #CancerResearch #MedicalBiophysics #UofT https://t…
-
-
Mashup Score: 1Addition of SBRT to Standard-of-Care Systemic Therapy in Oligoprogressive Disease - The ASCO Post - 4 month(s) ago
In the phase II CURB trial reported in The Lancet, Chiaojung Jillian Tsai, MD, PhD, and colleagues found that the addition of stereotactic body radiotherapy (SBRT) to standard-of-care systemic therapy was associated with improved progression-free survival in the total study population of patients with oligoprogressive non–small cell lung cancer (NSCLC) or breast cancer. Improvement was significant among patients with NSCLC but not among those with breast cancer. Chiaojung Jillian Tsai, MD, PhD In the
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet-
RT @adelapoite: Addition of SBRT to Standard-of-Care Systemic Therapy in Oligoprogressive Disease - The ASCO Post https://t.co/AyPLsGDx6j
-
-
Mashup Score: 3Research is key to transforming cancer outcomes - 6 month(s) ago
Sponsor Content
Source: www.theglobeandmail.comCategories: General Medicine News, Oncologists2Tweet-
RT @KevinSmithUHN: Research is key to transforming cancer outcomes - The Globe and Mail https://t.co/ZDkQpbGwYs
-
-
Mashup Score: 0Computed Tomography Images from Large Head and Neck Cohort (RADCURE) - The Cancer Imaging Archive (TCIA) Public Access - Cancer Imaging Archive Wiki - 11 month(s) ago
The RADCURE dataset was collected clinically for radiation therapy treatment planning and retrospectively reconstructed for quantitative imaging research. Acquisition and Validation Methods: RADCURE is comprised of data for 3,346 patients and contains computed tomography (CT) images with corresponding normal and non-normal tissue contours. CT scans were collected using systems from three…
Source: wiki.cancerimagingarchive.netCategories: Hem/Oncs, Latest HeadlinesTweet-
RADCURE is an amazing publicly available data set: 3,346 CT sim images from head and neck cancer patients with contours for tumor targets and 29 organs at risk collected from 2005-2017 treated with definitive RT @RadMedPM @pmcancercentre @UHN https://t.co/cM1gzW2qdL https://t.co/ppstxYQeq4
-
-
Mashup Score: 0How to Apply - 11 month(s) ago
Individuals who hold, or expect to hold, a Radiation Oncologist specialty certification in their own country are eligible to apply. Applications must include: a personal statement that also specifies the type of program and clinical sites of interest an updated CV 3 confidential reference letters sent directly from the referee to the program coordinator by email at…
Source: radonc.utoronto.caCategories: Hem/Oncs, Latest HeadlinesTweet-
Deadline to apply for a July 2024 #radonc fellowship @UofTDRO is June 30, 2023: https://t.co/8rHEvXkud5 @jenncroke @ldawsonmd @SahgalArjun @DrAndrewLoblaw
-
RT @naummalik: @DavidSherMD CCTG HN 13 led by Ian Poon @Sunnybrook will attempt to answer this question https://t.co/hMY3bjj9BI